Literature DB >> 14755217

Multicenter initiative seeking critical genes in respiratory papillomatosis.

Farrel J Buchinsky1, Craig S Derkay, Suzanne M Leal, Joseph Donfack, Garth D Ehrlich, J Christopher Post.   

Abstract

OBJECTIVES: To determine the host genes that govern susceptibility to recurrent respiratory papillomatosis (RRP). RRP is caused by human papillomavirus (HPV) 6 and 11. Millions of babies are exposed during the birthing process, but relatively few develop the disease and the aggressiveness of the course is highly variable. Genetically encoded host susceptibility is postulated. Determining the host genes that govern susceptibility will enhance our understanding not only of RRP but also of host-viral interaction in general. STUDY
DESIGN: A genome-wide association study on familial triads consisting of an RRP-affected child and his or her parents. Using the HapMap data from the human genome project, we will identify those alleles that are over-transmitted by the parents to their affected offspring as compared to those alleles that are under-transmitted.
METHODS: Approximately 400 patients and their parents will be recruited through a collaboration between the Center for Genomic Sciences and the RRP Task Force. DNA will be extracted from blood specimens and viral typing will be performed on biopsy specimens. Patients will be genotyped using single nucleotide polymorphism (SNP) markers and compared to their respective parents' genotype using the transmission disequilibrium test. Both a genome scan and a candidate gene approach will be utilized. RESULTS Institutional Review Board authorization has been obtained at three hospitals and the process is underway at 18 more. Patient and parent recruitment has begun. Specimens have been forwarded to Pittsburgh, Pennsylvania, where the DNA has been extracted and is being stored.
CONCLUSIONS: A novel approach combining a nationwide patient resource and the mapping power of the sub-centimorgan human haplotype map has been developed to elucidate the biological mechanisms of RRP by determining the genetically encoded susceptibilities of host-virus interaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755217      PMCID: PMC6141032          DOI: 10.1097/00005537-200402000-00032

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  59 in total

1.  Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

Authors:  A Storey; M Thomas; A Kalita; C Harwood; D Gardiol; F Mantovani; J Breuer; I M Leigh; G Matlashewski; L Banks
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

2.  Characterization of human papillomavirus in airway papillomas by histologic and biochemical analysis.

Authors:  M Glynn; T Sanford; L Hoover; W Kinsey; L Dobbs; D Bruegger
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-11       Impact factor: 1.547

3.  Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors.

Authors:  F L Rimell; D L Shoemaker; A M Pou; J A Jordan; J C Post; G D Ehrlich
Journal:  Laryngoscope       Date:  1997-07       Impact factor: 3.325

Review 4.  Considering genetic profiles in functional studies of immune responsiveness to HIV-1.

Authors:  M Carrington; G Nelson; S J O'Brien
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

5.  The cost of juvenile-onset recurrent respiratory papillomatosis.

Authors:  D Bishai; H Kashima; K Shah
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-08

6.  Prevalence of human papillomavirus types 11, 16 and 18 in cervical swabs. A study of 1362 pregnant women.

Authors:  U Hørding; A K Iversen; A Sebbelov; J E Bock; B Norrild
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1990 May-Jun       Impact factor: 2.435

Review 7.  The genomics and genetics of human infectious disease susceptibility.

Authors:  A V Hill
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

8.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial.

Authors:  G B Healy; R D Gelber; A L Trowbridge; K M Grundfast; R J Ruben; K N Price
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

10.  Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14.

Authors:  F Z Hu; R A Preston; J C Post; G J White; L W Kikuchi; X Wang; S M Leal; M A Levenstien; J Ott; T W Self; G Allen; R S Stiffler; C McGraw; E A Pulsifer-Anderson; G D Ehrlich
Journal:  JAMA       Date:  2000-07-19       Impact factor: 56.272

View more
  5 in total

Review 1.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

2.  Laryngeal papillomatosis: morphological study by light and electron microscopy of the HPV-6.

Authors:  Regina Helena Garcia Martins; Norimar H Dias; Elisa Aparecida Gregório; Mariângela Alencar Marques; Márcia Guimarães da Silva; João Manuel Grisi Candeias
Journal:  Braz J Otorhinolaryngol       Date:  2008 Jul-Aug

Review 3.  Recurrent respiratory papillomatosis: current and future perspectives.

Authors:  Marco Carifi; Domenico Napolitano; Morando Morandi; Danilo Dall'Olio
Journal:  Ther Clin Risk Manag       Date:  2015-05-05       Impact factor: 2.423

4.  Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis.

Authors:  Farrel J Buchinsky; William L Valentino; Nicole Ruszkay; Evan Powell; Craig S Derkay; Riaz Y Seedat; Virgilijus Uloza; Frederik G Dikkers; David E Tunkel; Sukgi S Choi; Anthony J Mortelliti; Paolo Campisi; Juan C Ospina; Adam J Donne; Robert T Sataloff; Stephen F Conley; John E McClay; Ellen M Friedman; Lisa Elden; Dale A Tylor; Clark A Rosen; Libby J Smith; Graeme J Copley; David E Karas; John M Schweinfurth; Charles M Myer; Brian J Wiatrak; Joseph E Dohar; Steven E Sobol; Robert W Bastian; Richard J H Smith; Marshall E Smith; Abebe M Wassie; James C Post; Garth D Ehrlich
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

5.  Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis.

Authors:  Farrel J Buchinsky; Joseph Donfack; Craig S Derkay; Sukgi S Choi; Stephen F Conley; Charles M Myer; John E McClay; Paolo Campisi; Brian J Wiatrak; Steven E Sobol; John M Schweinfurth; Domingos H Tsuji; Fen Z Hu; Howard E Rockette; Garth D Ehrlich; J Christopher Post
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.